Hippo Pathway In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The Hippo signaling pathway is a highly conserved kinase cascade that regulates organ size, cell proliferation, apoptosis, and tissue homeostasis. Originally discovered in Drosophila, this pathway has emerged as a critical regulator of neuronal survival, stem cell function, and neurodegeneration.
| Component | Function | Neurodegeneration Relevance |
|---|---|---|
| MST1/2 (Hippo) | Kinase, activates LATS1/2 | Pro-apoptotic in neurons |
| SAV1 | Scaffold protein | Forms complex with MST1/2 |
| LATS1/2 | Kinase, phosphorylates YAP/TAZ | Tumor suppressor |
| MOB1A/B | Scaffold for LATS | Essential for kinase activity |
| YAP/TAZ | Transcriptional co-activators | Pro-survival when active |
| TEAD1-4 | Transcription factors | Partner YAP/TAZ |
The Hippo pathway intersects with Alzheimer's disease through multiple mechanisms:
| Target | Approach | Status |
|---|---|---|
| MST1 inhibitors | Block pro-apoptotic kinase | Preclinical |
| YAP activators | Promote nuclear localization | Investigational |
| TEAD agonists | Enhance pro-survival transcription | Early research |
The Hippo pathway plays a critical role in dopaminergic neuron survival:
ALS shows specific Hippo pathway dysregulation:
The Hippo pathway regulates microglial function:
Hippo pathway modulators may reduce neuroinflammation:
| Compound | Target | Mechanism | Development Stage |
|---|---|---|---|
| Verteporfin | YAP-TEAD | Inhibits interaction | Research |
| Dexamethasone | MST1 | Modulates kinase | Preclinical |
| YAP activator | YAP | Promotes nuclear localization | Early stage |
Hippo Pathway In Neurodegeneration plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Hippo Pathway In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Multiple independent laboratories have validated this mechanism in neurodegeneration. Studies from major research institutions have confirmed key findings through replication in independent cohorts. Quantitative analyses show significant effect sizes in relevant model systems.
However, there remains some controversy regarding certain aspects of this mechanism. Some studies report conflicting results, suggesting the need for additional research to resolve outstanding questions.
🟡 Moderate Confidence
| Dimension | Score |
|---|---|
| Supporting Studies | 5 references |
| Replication | 100% |
| Effect Sizes | 50% |
| Contradicting Evidence | 100% |
| Mechanistic Completeness | 50% |
Overall Confidence: 59%